Related Experiment Videos
Antilymphocyte globulin in the treatment of advanced Sézary syndrome
Lancet (London, England)
|May 1, 1976
Abstract:
Two patients with Sézary syndrome, refractory to conventional treatment, were given cyclophosphamide and antilymphocyte globulin (A.L.G) Both patients showed improvement. One patient subsequently died from widespread varicella and the other relapsed later. It is concluded that A.L.G. may be effective in this condition.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Changes in student physical health behaviour: an opportunity to turn the concept of a Healthy University into a reality.
Perspectives in public health·2018
Monellin (MNEI) at 1.15 A resolution.
Acta crystallographica. Section F, Structural biology and crystallization communications·2007
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2006
Migraine.
Lancet (London, England)·2026
Governing the digital determinants of health for children and young people: a global public health imperative.
Lancet (London, England)·2026
The digital determinants of health: a new era for global public health.
Lancet (London, England)·2026
Jujuboside A inhibits the progression of ischemic stroke by regulating miR-583.
Xenobiotica; the fate of foreign compounds in biological systems·2026
Enhancement of hippocampal synaptic AMPA receptor function by the antidepressant tianeptine and by opioid peptides.
Proceedings of the National Academy of Sciences of the United States of America·2026